Condition
Lymphoma, Mantle-Cell clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Lymphoma, Mantle-Cell clinical trials that are recruiting, at sites in 15 countries (most in France (2), Australia (2), United Kingdom (2)). By phase: Phase 2 (2), Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 15Countries
Newest Lymphoma, Mantle-Cell clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| New therapy dose test for people with prior B-cell cancers | Phase 1 | Duarte, California and 50 other locations | Recruiting | Aug 3, 2025 |
| Evaluating Glofitamab with Venetoclax and Zanubrutinib for high-risk Mantle-cell Lymphoma | Phase 2 | Bruges and 15 other locations | Recruiting | Aug 16, 2024 |
| Combining Zanubrutinib with Bendamustine and Rituximab for Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 18, 2023 |
| Treatment of B-cell malignancies with ALETA-001 | Phase 1/2 | Birmingham and 6 other locations | Recruiting | Sep 21, 2023 |
| Testing PEP07 for advanced cancer treatment | Phase 1 | Clayton, Victoria and 4 other locations | Recruiting | Dec 21, 2022 |
All recruiting trials (5)
-
New therapy dose test for people with prior B-cell cancers
This early-phase study tests different doses of LY4152199 to see if it is safe and effective for people who have already been treated for certain B-cell lymphomas.
-
Evaluating Glofitamab with Venetoclax and Zanubrutinib for high-risk Mantle-cell Lymphoma
This study is testing a new combination of treatments for people with high-risk Mantle-cell Lymphoma to see if it helps them better than current options.
-
Combining Zanubrutinib with Bendamustine and Rituximab for Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma
This study is testing if combining a new drug called Zanubrutinib with two other treatments can help older patients with newly diagnosed mantle cell lymphoma feel better and improve their health.
-
Treatment of B-cell malignancies with ALETA-001
This study is testing a new treatment called ALETA-001 to see if it can help people with relapsed non-Hodgkin lymphoma who didn't respond well to previous therapies.
-
Testing PEP07 for advanced cancer treatment
This study is testing a new oral treatment called PEP07 to see if it is safe and tolerable for people with advanced blood cancers like Acute Myeloid Leukemia and Mantle Cell Lymphoma.
Related topics
Quick answers
How many Lymphoma, Mantle-Cell clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in France (2 trials), Australia (2 trials), United Kingdom (2 trials), China (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.